{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:56:23Z","timestamp":1776113783657,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA041449"],"award-info":[{"award-number":["DA041449"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH1112473"],"award-info":[{"award-number":["MH1112473"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005337","name":"American Academy of Child and Adolescent Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12519-026-01028-3","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:01:01Z","timestamp":1774548061000},"page":"372-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of pediatric cannabidiol prescribing in the United States"],"prefix":"10.1007","volume":"22","author":[{"given":"Yifan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio A.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob T.","family":"Borodovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Gano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Trestman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kablinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallawi","family":"Jyotsana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Steinle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6652-2109","authenticated-orcid":false,"given":"Binx Yezhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"1028_CR1","unstructured":"Jazz Pharmaceuticals. Safety profile of EPIDIOLEX\u00ae (cannabidiol). 2024. https:\/\/www.epidiolexhcp.com\/efficacy-and-safety\/safety. Accessed 18 Apr 2025."},{"key":"1028_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-018-0186-y","volume":"14","author":"S Balan","year":"2018","unstructured":"Balan S, Hassali MAA, Mak VSL. Two decades of off-label prescribing in children: A literature review. World J Pediatr. 2018;14:528\u201340. https:\/\/doi.org\/10.1007\/s12519-018-0186-y.","journal-title":"World J Pediatr"},{"key":"1028_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/can.2024.0001","volume":"10","author":"A David","year":"2025","unstructured":"David A, Stolar O, Berkovitch M, Kohn E, Hazan A, Waissengreen D, et al. Effects of medical Cannabis treatment for autistic children on anxiety and restricted and repetitive behaviors and interests: An open-label study. Cannabis Cannabinoid Res. 2025;10:537\u201348. https:\/\/doi.org\/10.1089\/can.2024.0001.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1028_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01521","volume":"9","author":"D Barchel","year":"2018","unstructured":"Barchel D, Stolar O, De-Haan T, Ziv-Baran T, Saban N, Fuchs DO, et al. Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Front Pharmacol. 2018;9:1521. https:\/\/doi.org\/10.3389\/fphar.2018.01521.","journal-title":"Front Pharmacol"},{"key":"1028_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamapediatrics.2021.0367","volume":"175","author":"R Kachru","year":"2021","unstructured":"Kachru R, Perry-Lunardo C, Thompson LA. CBD use in children-miracle, myth, or mystery? JAMA Pediatr. 2021;175:652. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.0367.","journal-title":"JAMA Pediatr"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/epi4.12956","volume":"9","author":"RT Wechsler","year":"2024","unstructured":"Wechsler RT, Burdette DE, Gidal BE, Hyslop A, McGoldrick PE, Thiele EA, et al. Consensus panel recommendations for the optimization of EPIDIOLEX\u00ae treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Epilepsia Open. 2024;9:1632\u201342. https:\/\/doi.org\/10.1002\/epi4.12956.","journal-title":"Epilepsia Open"},{"key":"1028_CR7","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1172\/JCI139051","volume":"130","author":"YL Hurd","year":"2020","unstructured":"Hurd YL. Cannabis and the developing brain challenge risk perception. J Clin Invest. 2020;130:3947\u20139. https:\/\/doi.org\/10.1172\/JCI139051.","journal-title":"J Clin Invest"},{"key":"1028_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100303","volume":"13","author":"BY Lin","year":"2024","unstructured":"Lin BY, Lessard C, Li Y, Gong L, Ling R, Jyotsana P, et al. Cannabidiol prescribing in the United States: An analysis of real-world data. Drug Alcohol Depend Rep. 2024;13:100303. https:\/\/doi.org\/10.1016\/j.dadr.2024.100303.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1028_CR9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1818","volume":"140","author":"SS Wong","year":"2017","unstructured":"Wong SS, Wilens TE. Medical cannabinoids in children and adolescents: A systematic review. Pediatrics. 2017;140:e20171818. https:\/\/doi.org\/10.1542\/peds.2017-1818.","journal-title":"Pediatrics"},{"key":"1028_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532","volume":"363","author":"SM Langan","year":"2018","unstructured":"Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532. https:\/\/doi.org\/10.1136\/bmj.k3532.","journal-title":"BMJ"},{"key":"1028_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12:1495\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014.","journal-title":"Int J Surg"},{"key":"1028_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101201","volume":"37","author":"VH Ahlqvist","year":"2024","unstructured":"Ahlqvist VH, Dardani C, Madley-Dowd P, Forbes H, Rast J, Zhong C, et al. Psychiatric comorbidities in epilepsy: population co-occurrence, genetic correlations and causal effects. gen psychiatry. 2024;37:e101201. https:\/\/doi.org\/10.1136\/gpsych-2023-101201.","journal-title":"gen psychiatry"},{"key":"1028_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00787-023-02169-w","volume":"33","author":"LJ Rice","year":"2024","unstructured":"Rice LJ, Cannon L, Dadlani N, Cheung MMY, Einfeld SL, Efron D, et al. Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review. eur child adolesc psychiatry. 2024;33:505\u201326. https:\/\/doi.org\/10.1007\/s00787-023-02169-w.","journal-title":"eur child adolesc psychiatry"},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1007\/s11606-020-06504-8","volume":"36","author":"P Balachandran","year":"2021","unstructured":"Balachandran P, Elsohly M, Hill KP. Cannabidiol interactions with medications, illicit substances, and alcohol: a comprehensive review. j gen intern med. 2021;36:2074\u201384. https:\/\/doi.org\/10.1007\/s11606-020-06504-8.","journal-title":"j gen intern med"},{"key":"1028_CR15","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/epi.16355","volume":"60","author":"LL Anderson","year":"2019","unstructured":"Anderson LL, Absalom NL, Abelev SV, Low IK, Doohan PT, Martin LJ, et al. Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions. Epilepsia. 2019;60:2224\u201334. https:\/\/doi.org\/10.1111\/epi.16355.","journal-title":"Epilepsia"},{"key":"1028_CR16","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. n engl j med. 2018;378:1888\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1714631.","journal-title":"n engl j med"},{"key":"1028_CR17","doi-asserted-by":"publisher","first-page":"e769","DOI":"10.1542\/peds.2014-4147","volume":"135","author":"S Ammerman","year":"2015","unstructured":"Ammerman S, Ryan S, Adelman WP, Committee on Substance Abuse TCOA. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. 2015;135:e769\u201385. https:\/\/doi.org\/10.1542\/peds.2014-4147.","journal-title":"Pediatrics"},{"key":"1028_CR18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-1889","volume":"142","author":"SA Ryan","year":"2018","unstructured":"Ryan SA, Ammerman SD, O\u2019Connor ME, Committee on substance use and prevention, section on breastfeeding. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics. 2018;142:e20181889. https:\/\/doi.org\/10.1542\/peds.2018-1889.","journal-title":"Pediatrics"},{"key":"1028_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5863\/1551-6776-28.4.323","volume":"28","author":"K Schwaller","year":"2023","unstructured":"Schwaller K, Krauss Z, Chen AMH, Cole JW. Parental perceptions and usage of unlicensed cannabidiol products in children with anxiety and neurodevelopmental disorders. J Pediatr Pharmacol Ther. 2023;28:323\u20138. https:\/\/doi.org\/10.5863\/1551-6776-28.4.323.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"1028_CR20","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318:1708\u20139. https:\/\/doi.org\/10.1001\/jama.2017.11909.","journal-title":"JAMA"},{"key":"1028_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/epi4.13105","volume":"10","author":"KY Xu","year":"2025","unstructured":"Xu KY, Lin BY, Perry MS, Nascimento FA. Antiseizure medication prescribing in people with Dravet syndrome: an analysis of real-time administrative data. Epilepsia Open 2025;10:336\u201341. https:\/\/doi.org\/10.1002\/epi4.13105.","journal-title":"Epilepsia Open"},{"key":"1028_CR22","doi-asserted-by":"publisher","unstructured":"Marcinski Nascimento KJ, Li Y, Lin BY, Dixon-Salazar T, Perry MS, Xu KY, et al. A temporary spike: investigating Lennox\u2013Gastaut syndrome incidence in the US following FDA approval of cannabidiol. Epileptic Disord. 2026:epd2.70168. https:\/\/doi.org\/10.1002\/epd2.70168.","DOI":"10.1002\/epd2.70168"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-026-01028-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-026-01028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:36:41Z","timestamp":1776109001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-026-01028-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s12519-026-01028-3","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The contents of this publication are solely the responsibility of the author and do not necessarily represent the official views of the Department of Health and Human Services, American Psychiatric Association, or American Psychiatric Association Foundation. Mention of trade names, commercial practices, or organizations does not imply endorsement by the U.S. Government. The funding sources had no role in the study design, implementation, or interpretation of results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Carilion Clinic Institutional Review Board (IRB-23\u20132016) determined the study to be a nonhuman subject research project given that TriNetX contains only de-identified population-level data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}